Announcements
- 2025.09.26 (I) PROPOSED GRANTING OF GENERAL MANDATE TO ISSUE SHARES; AND (2) NOTICE OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING
- 2025.09.25 2025 Interim Report
- 2025.09.04 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
- 2025.08.27 INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
- 2025.08.15 NOTICE OF BOARD MEETING
- 2025.08.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
- 2025.07.21 VOLUNTARY ANNOUNCEMENT - THE SUCCESSFUL COMPLETION OF KEN-VALVE'S FIRST BATCH OF COMMERCIAL IMPLANTATIONS
- 2025.07.04 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
- 2025.06.27 VOLUNTARY ANNOUNCEMENT THE 30-DAY CLINICAL FOLLOW-UP RESULTS FOR LARGE ANNULUS PATIENTS OF LUX-VALVE PLUS TRINITY STUDY RELEASED AT NEW YORK VALVES 2025 IN THE U.S.
- 2025.06.03 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
